Fondaparinux indications

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Fondaparinux sodium (Arixtra) Injection is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism:

• in patients undergoing hip fracture surgery, including extended prophylaxis;
• in patients undergoing hip replacement surgery;
• in patients undergoing knee replacement surgery;
• in patients undergoing abdominal surgery who are at risk for thromboembolic complications.

Fondaparinux sodium (Arixtra) Injection is indicated for:

• the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium, and
• the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital.

Adapted from the FDA Package Insert.